References
- Spiller HA, Hays HL, Aleguas A. Overdose of drugs for attention-deficit hyperactivity disorder: clinical presentation, mechanisms of toxicity, and management. CNS Drugs. 2013;27(7):531–543.
- Subcommittee on Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128(5):1007–1022.
- LoVecchio F, Ozimek J, Sawyers B, et al. Outcomes after accidental pediatric ingestions of (dextro)amphetamine and methylphenidate. Am J Emerg Med. 2009;27(8):933–934.
- Derlet RW, Rice P, Horowitz BZ, et al. Amphetamine toxicity: experience with 127 cases. J Emerg Med. 1989;7(2):157–161.
- Zalis EG, Parmley LF. Fafal amphetamine poisoning. Arch Intern Med. 1963;112(6):822–826.
- King SA, Casavant MJ, Spiller HA, et al. Pediatric ADHD medication exposures reported to US poison control centers. Pediatrics. 2018;141(6):e20173872–13.
- Wood KE, McCarthy PJ, Krasowski MD. A case series involving young children presenting with accidental ingestion of amphetamine based stimulants. Toxicol Rep. 2018;5:1129–1133.
- Scharman EJ, Erdman AR, Cobaugh DJ, et al. Methylphenidate poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 2007;45(7):737–752.
- Huffman RM, McCaughey J, Hays H, et al. Lisdexamfetamine (Vyvanse(r)) exposure in children 5 years of age and under: stay or go? is a trip the emergency department necessary? (abstract). Clin Toxicol (Phila). 2013;51(7):599.
- Biederman J, Lopez FA, Boellner SW, et al. A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder. Pediatrics. 2002;110(2):258–266.
- Ahmann PA, Theye FW, Berg R, et al. Placebo-controlled evaluation of amphetamine mixture-dextroamphetamine salts and amphetamine salts (Adderall): efficacy rate and side effects. Pediatrics. 2001;107(1):E10–e10.
- Novak MJ, DesLauriers C, Wahl M. Pediatric ingestions of amfetamine/dextroamfetamine salts (abstract). Clin Toxicol (Phila). 2017;55(7):720–721.
- Catalá-López F, Hutton B, Núñez-Beltrán A, et al. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: a systematic review with network meta-analyses of randomised trials. PLoS One. 2017;12(7):e0180355.
- Ermer JC, Adeyi BA, Pucci ML. Pharmacokinetic variability of long-acting stimulants in the treatment of children and adults with attention-deficit hyperactivity disorder. CNS Drugs. 2010;24(12):1009–1025.
- Spiller HA, Bosse GM, Beuhler M, et al. Unintentional ingestion of bupropion in children. J Emerg Med. 2010;38(3):332–336.
- Hays H, Beuhler MC, Spiller HA. Adverse outcomes after single acute methotrexate exposures in pediatric patients are rare. Clin Toxicol (Phila). 2018;56(9):870–871.
- Hays H, Beuhler MC, Spiller HA, et al. Evaluation of toxicity after acute accidental methotrexate ingestions in children under 6 years old: a 16-year multi-center review. Clin Toxicol (Phila). 2018;56(2):120–125.